Psychemedics Corp (PMD, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Psychemedics Corp provides testing services for the detection of drugs of abuse through the analysis of hair samples. This information is useful to employers for both applicant and employee testing, as well as to physicians and among others. Psychemedics Corp has a market cap of $110.070 million; its shares were traded at around $20.04 with a P/E ratio of 18.22 and P/S ratio of 2.72. The dividend yield of Psychemedics Corp stocks is 2.99%. Psychemedics Corp had annual average EBITDA growth of 0.60% over the past ten years.
For the last quarter Psychemedics Corp reported a revenue of $9.76 million, compared with the revenue of $10.76 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $39.7 million, an increase of 1.8% from last year. For the last five years Psychemedics Corp had an average revenue growth rate of 9.9% a year.
The reported diluted earnings per share was $1.1 for the year, a decline of 9.8% from the previous year. Over the last five years Psychemedics Corp had an EPS growth rate of 12.5% a year. The Psychemedics Corp had a decent operating margin of 20.55%, compared with the operating margin of 25.94% a year before. The 10-year historical median operating margin of Psychemedics Corp is 20.88%. The profitability rank of the company is 8 (out of 10).
At the end of the fiscal year, Psychemedics Corp has the cash and cash equivalents of $8.17 million, compared with $3.94 million in the previous year. The long term debt was $2.42 million, compared with $2.24 million in the previous year. Psychemedics Corp has a financial strength rank of 8 (out of 10).
At the current stock price of $20.04, Psychemedics Corp is traded at close to its historical median P/S valuation band of $18.70. The P/S ratio of the stock is 2.72, while the historical median P/S ratio is 2.55. The stock gained 4.61% during the past 12 months.
For the complete 20-year historical financial data of PMD, click here.
